RE:Is U.S. FDA the centre of the biotech universe?bullcycle wrote: And the success or failure of the company depends entirely on FDA approval? Has the management been working hard to achieve Canadian FDA approval right here at home, European FDA approval, FDA approval in Asia, in Australia and in the Middle East? America, though with the population of 400 million therefore a big market for drugs, it is only 5% of the global demand among global cancer patients. Does the management think the approval by other jurisdiction around the world depends entirely on the approval by U.S. FDA? With approval developed around the world Telesta and Ipsen could be sell MCNA in Canada, Europe, Asia, Austria, Middle East and share price should be shooting through $1. With established approval around the world, Telesta's Market Cap will be well over $500 million and it will great enhance shareholders value should shareholders want to sell the complete company. With established MCNA approval around the world buyout price could be between $1 and $2 !!!
As I mentioned a couple times before, I take with a grain of salt what an sp "should be". Sure, we can say it should be over $1. That'd be great. but I've yet to see any SP have a valuation that some analysts say.
Speaking of MCNA in other parts of the world, I really wish we had more clarity on that. I say f*ck U.S. FDA and concentrate on the rest of the world. As I said before, USA isn't the only country in the world.